MannKind Corp. (NASDAQ: MNKD) saw its short interest increase to 105.71 million shares. The previous reading was 103.74 million. Shares closed most recently at $0.95, in a 52-week trading range of $0.64 to $7.32.
The company still doesn't advertise Afrezza and will never advertise for it. The smart ones sold at nearly $8 or $4. Its amazing that people still defend this company. Look at any chart on yahoo finance from 1 day to 1 year all ugly
how is the story related to arni other than they paid for the content. Arni isn't mentioned in the article. Does Dr. Holden work for ARNO?
anyone heard anything. The markman Hearing was two years ago. I guess the department of justice is trying to stall this thing until WDDD falls below .01.
I sold mnkd at 4 and you're calling me dumb. You are holding this pos still that has no advertising no, no money and no prospects
only question is where is the advertising and PR? We were told there was going to be a major advertising campaign yet I have yet to see anything on TV, on the web, in newspapers and in magazines. Yet I can't go a minute without seeing an ad for another diabetes product Lyrica, liberal medical, Toujeo